Daniel W Armstrong is a Professor at the University of Texas at Arlington in the Department of Chemistry and Biochemistry. With over 35 years of experience, he is a pioneering figure in chiral recognition, enantiomeric separations, and the biological relevance of D-amino acids. His work has led to over 740 publications, 35 patents, and 560 invited seminars worldwide. Developed first chiral recognition mechanism by cyclodextrins First to use macrocyclic antibiotics as chiral selectors Synthesized most new ionic liquids (ILs) globally Created ultra-fast separation techniques now standard in analytical chemistry Contributed to FDA 1992 guidelines on chiral drug separation His research focuses on chiral separations, ionic liquids, and the role of D-amino acids in biological systems. He has commercialized over 30 HPLC and GC columns, transforming analytical chemistry and pharmaceutical analysis. Recent publications demonstrate continued innovation in chiral chromatography, biomarker analysis, and AI-driven separation optimization. His grants include industry collaborations with Merck, Alcon, and Sigma-Aldrich, emphasizing practical applications of his work. Scientific honors include multiple lifetime achievement awards, fellowships in the Royal Society of Chemistry and American Chemical Society, the Chirality Medal, and induction into the National Academy of Inventors. He has mentored over 100 PhD students, many from first-generation college backgrounds.









